53
https://pubmed.ncbi.nlm.nih.gov/38117563
The 2019 ASCCP Risk-Based Management Consensus Guidelines have been updated through 2023 with changes including endorsement of HIV/immunosuppressed opportunistic infection guidelines and revised management recommendations for cervical intraepithelial neoplasia and unsatisfactory cytology.